Multiparametric magnetic resonance imaging for the assessment of non-alcoholic fatty liver disease severity.

scientific article

Multiparametric magnetic resonance imaging for the assessment of non-alcoholic fatty liver disease severity. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1111/LIV.13284
P932PMC publication ID5518289
P698PubMed publication ID27778429

P50authorEleanor J. BarnesQ32637041
Michael PavlidesQ43405332
Kenneth FlemingQ46098555
Elizabeth M TunnicliffeQ51100253
P2093author name stringStefan Neubauer
Matthew D Robson
Rajarshi Banerjee
Jane Collier
Lai Mun Wang
Catherine Kelly
Jeremy F Cobbold
P2860cites workDesign and validation of a histological scoring system for nonalcoholic fatty liver diseaseQ29614930
The natural history of nonalcoholic fatty liver disease: a population-based cohort studyQ29617161
Magnetic resonance elastography is superior to acoustic radiation force impulse for the Diagnosis of fibrosis in patients with biopsy-proven nonalcoholic fatty liver disease: A prospective study.Q30364476
Novel 3D Magnetic Resonance Elastography for the Noninvasive Diagnosis of Advanced Fibrosis in NAFLD: A Prospective Study.Q30366572
Multiparametric magnetic resonance imaging predicts clinical outcomes in patients with chronic liver diseaseQ30389327
Magnetic resonance elastography predicts advanced fibrosis in patients with nonalcoholic fatty liver disease: a prospective studyQ30418856
Multiparametric magnetic resonance for the non-invasive diagnosis of liver diseaseQ30445138
MRI-based estimation of liver function: Gd-EOB-DTPA-enhanced T1 relaxometry of 3T vs. the MELD scoreQ33858748
Shortened Modified Look-Locker Inversion recovery (ShMOLLI) for clinical myocardial T1-mapping at 1.5 and 3 T within a 9 heartbeat breathholdQ34403474
Transient elastography: a new noninvasive method for assessment of hepatic fibrosis.Q34544284
Wedge and needle liver biopsies show discordant histopathology in morbidly obese patients undergoing Roux-en-Y gastric bypass surgeryQ37615609
Systematic review with meta-analysis: non-invasive assessment of non-alcoholic fatty liver disease--the role of transient elastography and plasma cytokeratin-18 fragmentsQ38168939
Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studiesQ38207382
Magnetic Resonance Imaging More Accurately Classifies Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease Than Transient Elastography.Q41042091
Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United StatesQ41626076
Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-upQ42201783
Utility and appropriateness of the fatty liver inhibition of progression (FLIP) algorithm and steatosis, activity, and fibrosis (SAF) score in the evaluation of biopsies of nonalcoholic fatty liver diseaseQ44227516
No significant effects of ethyl-eicosapentanoic acid on histologic features of nonalcoholic steatohepatitis in a phase 2 trialQ44997998
Pitfalls of liver stiffness measurement: a 5-year prospective study of 13,369 examinationsQ46078112
Limited value of plasma cytokeratin-18 as a biomarker for NASH and fibrosis in patients with non-alcoholic fatty liver disease.Q46124754
Sampling variability of liver fibrosis in chronic hepatitis C.Q48583601
A population-based study on the prevalence of NASH using scores validated against liver histology.Q51330074
MR relaxometry of the liver: significant elevation of T1 relaxation time in patients with liver cirrhosis.Q51431525
Prevalence of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis Among a Largely Middle-Aged Population Utilizing Ultrasound and Liver Biopsy: A Prospective StudyQ51541188
A model for hepatic fibrosis: the competing effects of cell loss and iron on shortened modified Look-Locker inversion recovery T1 (shMOLLI-T1 ) in the liver.Q53062749
Prevalence of non-alcoholic fatty liver disease and advanced fibrosis in Hong Kong Chinese: a population study using proton-magnetic resonance spectroscopy and transient elastographyQ61567953
Usefulness of T1 mapping on Gd-EOB-DTPA-enhanced MR imaging in assessment of non-alcoholic fatty liver diseaseQ87164941
Liver stiffness measurement using XL probe in patients with nonalcoholic fatty liver diseaseQ87406034
P433issue7
P921main subjectliver diseaseQ929737
metabolic dysfunction–associated steatotic liver diseaseQ1546498
non-alcoholic fatty liverQ66299798
P304page(s)1065-1073
P577publication date2017-05-30
P1433published inLiver InternationalQ15765078
P1476titleMultiparametric magnetic resonance imaging for the assessment of non-alcoholic fatty liver disease severity
P478volume37

Reverse relations

cites work (P2860)
Q99564871A composite biomarker using multiparametric magnetic resonance imaging and blood analytes accurately identifies patients with non-alcoholic steatohepatitis and significant fibrosis
Q91600205Defining Improvement in Nonalcoholic Steatohepatitis for Treatment Trial Endpoints: Recommendations From the Liver Forum
Q90640984Dysregulated liver lipid metabolism and innate immunity associated with hepatic steatosis in neonatal BBdp rats and NOD mice
Q61796245Evolving role of magnetic resonance techniques in primary sclerosing cholangitis
Q64228361High performance of intravoxel incoherent motion diffusion MRI in detecting viral hepatitis-b induced liver fibrosis
Q48101341Imaging prediction of nonalcoholic steatohepatitis using computed tomography texture analysis
Q92419433Liver MR relaxometry at 3T - segmental normal T1 and T2* values in patients without focal or diffuse liver disease and in patients with increased liver fat and elevated liver stiffness
Q100994722Magnetic resonance-based biomarkers in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
Q89143797Non-invasive assessment of liver disease in rats using multiparametric magnetic resonance imaging: a feasibility study
Q92727108Non-invasive assessment of portal hypertension by multi-parametric magnetic resonance imaging of the spleen: A proof of concept study
Q57173225Noninvasive biomarkers in NAFLD and NASH - current progress and future promise
Q57069715Obesity and nonalcoholic fatty liver disease: current perspectives
Q48170451Origins of Portal Hypertension in Nonalcoholic Fatty Liver Disease.
Q38614820Quantitative MRI of fatty liver disease in a large pediatric cohort: correlation between liver fat fraction, stiffness, volume, and patient-specific factors
Q91841927Radiomics based on artificial intelligence in liver diseases: where we are?
Q57170235Recent research trends and updates on nonalcoholic fatty liver disease
Q64061112Repeatability and reproducibility of multiparametric magnetic resonance imaging of the liver
Q94475611Road to identifying endpoint biomarkers in the treatment of nonalcoholic steatohepatitis: are we there yet?
Q46476704Role of imaging-based biomarkers in NAFLD: Recent advances in clinical application and future research directions
Q47260332Utility and cost evaluation of multiparametric magnetic resonance imaging for the assessment of non-alcoholic fatty liver disease.
Q58760217Utility and variability of three non-invasive liver fibrosis imaging modalities to evaluate efficacy of GR-MD-02 in subjects with NASH and bridging fibrosis during a phase-2 randomized clinical trial